SCHEMBL13622878

SCHEMBL13622878

Cc1c(COc2ccccc2)c(C)c(OCc2ccccc2)c(C)c1COc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
PTGS1 P23219 1/20 0.50
SLC6A2 P23975 1/20 0.50
CYP2C19 P33261 1/20 0.50
PTGS2 P35354 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HIF1A Q16665 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
MAOB P27338 7/20 0.49
MAPT P10636 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
APP P05067 1/20 0.49
MAPK1 P28482 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
GAA P10253 1/20 0.49
MAOA P21397 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
BCHE P06276 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12129561 0.85 KCNH2 (0.50) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL24968079 0.81 L3MBTL1 (0.63) LMNACYP1A2PTGS1SLC6A2CYP2C19
Benzylphenylether SCHEMBL61660 0.79 LMNA (0.74) LMNACYP1A2PTGS1SLC6A2CYP2C19
Benzylphenylether SCHEMBL10872821 0.77 LMNA (0.72) LMNACYP1A2PTGS1SLC6A2CYP2C19
Benzylphenylether SCHEMBL8019776 0.77 LMNA (0.71) LMNACYP1A2PTGS1SLC6A2CYP2C19
Benzylphenylether SCHEMBL9283359 0.77 LMNA (0.71) LMNACYP1A2PTGS1SLC6A2CYP2C19
Benzylphenylether SCHEMBL23235842 0.77 LMNA (0.71) LMNACYP1A2PTGS1SLC6A2CYP2C19
Benzylphenylether SCHEMBL9549322 0.77 LMNA (0.71) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL10609652 0.75 LMNA (0.75) LMNACYP1A2PTGS1SLC6A2CYP2C19
Benzylphenylether SCHEMBL22499954 0.75 LMNA (0.68) LMNACYP1A2PTGS1SLC6A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090289224-A1 COMPOUND COMPRISING PHENYL PYRIDINE UNITS GENERAL ELECTRIC COMPANY (US) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090289224-A1 COMPOUND COMPRISING PHENYL PYRIDINE UNITS C1S, C3AR1, CRY1 LMNA 3839/4885CYP1A2 45/4885PTGS1 435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.